-
121
-
122
A Diagnosis of Maternal 22q Duplication and Mosaic Deletion following Prenatal Cell-Free DNA Screening
Published 2023-01-01“…The patient was referred to maternal-fetal medicine (MFM) at 14 weeks’ gestation secondary to an SNP-based cfDNA result of a suspected maternal 22q11.2 deletion and a fetal risk of 1 in 2 for 22q11.2 deletion syndrome. …”
Get full text
Article -
123
Acute and Chronic Fetal Anemia as a Result of Fetomaternal Hemorrhage
Published 2014-01-01Get full text
Article -
124
Current preeclampsia prediction model and biomarker
Published 2024-11-01“…Current prediction models recommended by notable organizations, including the National Institute for Health and Care Excellence (NICE), the American College of Obstetricians and Gynecologists (ACOG), the Fetal Medicine Foundation (FMF), and the World Health Organization (WHO), generally involve screening based on maternal characteristics and known risk factors. …”
Get full text
Article -
125
The Current Applications of Metabolomics in Understanding Endometriosis: A Systematic Review
Published 2025-01-01Get full text
Article -
126
Analysis of small extracellular vesicles from dried blood spots
Published 2025-01-01Get full text
Article -
127
-
128
Maternal and fetal arrhythmia as a sign of hemodynamic deterioration: a case report
Published 2024-02-01“…A pregnant woman aged 36 years was admitted to the division of maternal and fetal medicine at 34 weeks of gestation. She was gravida 4 and para 3. …”
Get full text
Article -
129
-
130
Management of a Novel Autoimmune Disease, COPA Syndrome, in Pregnancy
Published 2022-01-01“…Management of COPA syndrome should be performed by a multidisciplinary team including maternal-fetal medicine, rheumatology, and pulmonology specialists. …”
Get full text
Article -
131
Effectiveness of Different Algorithms and Cut-off Value in Preeclampsia First Trimester Screening
Published 2022-01-01“…All 801 patients had an estimated risk of eo-PE based on the Fetal Medicine Foundation algorithm. The patients were divided into four groups based on a risk calculation algorithm: 1) screening based on UtPI, MAP, and PlGF; 2) screening based on UtPI, MAP, PAPP-A, and PlGF; 3) screening based on UtPI, MAP, and PAPP-A; and 4) screening based on UtPI and MAP. …”
Get full text
Article -
132
Successful Management of Hemolytic Anemia Due to Rh-immunization, Diagnosed Antenatally
Published 2024-11-01“…Hemolytic disease of the fetus and newborn (HDFN) remains a significant concern in maternal-fetal medicine, despite advancements in prevention and management. …”
Get full text
Article -
133
-
134
-
135
-
136
Obesity Cut-Off Points Using Prepregnancy Body Mass Index according to Cardiometabolic Conditions in Pregnancy
Published 2023-01-01“…In this prospective study, singleton pregnant women from the fetal medicine service of the Brazilian Unified Health System were included. …”
Get full text
Article -
137
-
138
Longitudinal investigation of neurobiological changes across pregnancy
Published 2025-01-01Get full text
Article -
139
Placenta-Specific Protein 1: A Potential Key to Many Oncofetal-Placental OB/GYN Research Questions
Published 2014-01-01“…Mechanisms determining multiple PLAC1 transcripts and promoter preferences are as yet unknown, but it is clear that this protein is likely to be important in a variety of phenomena relevant to both gynecologic oncology and maternal-fetal medicine.…”
Get full text
Article -
140
Body image and sexual life satisfaction in women considering female genital cosmetic surgery in Iran
Published 2025-02-01Get full text
Article